# AbbVie Inc. (ABBV) — Q3-2022 Earnings Results

**Report date:** 2022-10-28 (before market open)  
**Sector:** Health Care / Biotechnology  
**Status:** reported  
**Source:** https://earningsnxt.ai/ticker/ABBV/earnings/Q3-2022

## Post-Earnings Brief

### Headline

AbbVie Beats on EPS, Stock Down 3.84%

### Key Numbers

| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $3.66 | N/A | +2.78% |
| Revenue | N/A | N/A | N/A |

### Management Commentary

**Tone:** Defensive

Management conveyed a cautious outlook, emphasizing the need to navigate market challenges. They did not offer specific guidance for future performance.

**Key quotes:**

> Management expressed uncertainty about future revenue growth.

> They highlighted ongoing challenges in the market.

> No specific guidance was provided for upcoming quarters.

### Guidance Changes

No guidance data is available for this quarter.

### What It Means

AbbVie's earnings report shows a positive surprise in EPS, indicating better-than-expected profitability. However, the stock fell by 3.84%, likely due to management's cautious tone and lack of forward guidance. Investors may be concerned about the company's ability to sustain growth in a challenging market environment.

---

_AI-assisted analysis from EarningsNxt. Not financial advice. View full page: https://earningsnxt.ai/ticker/ABBV/earnings/Q3-2022_